LYRDROI Trademark

Trademark Overview

On Thursday, November 1, 2012, a trademark application was filed for LYRDROI with the United States Patent and Trademark Office. The USPTO has given the LYRDROI trademark a serial number of 85769216. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 24, 2023. This trademark is owned by Glaxo Group Limited. The LYRDROI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
lyrdroi

General Information

Serial Number85769216
Word MarkLYRDROI
Filing DateThursday, November 1, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 24, 2023
Registration Number5015372
Registration DateTuesday, August 9, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 24, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Friday, February 24, 2023CANCELLED SEC. 8 (6-YR)
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 9, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 9, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, June 30, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, May 23, 2016NOTICE OF ALLOWANCE CANCELLED
Monday, May 23, 2016TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, October 27, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 26, 2015SOU EXTENSION 5 GRANTED
Wednesday, October 21, 2015SOU EXTENSION 5 FILED
Wednesday, October 21, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 4, 2015SOU EXTENSION 4 GRANTED
Thursday, April 30, 2015SOU EXTENSION 4 FILED
Thursday, April 30, 2015TEAS EXTENSION RECEIVED
Wednesday, November 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 4, 2014SOU EXTENSION 3 GRANTED
Thursday, October 30, 2014SOU EXTENSION 3 FILED
Thursday, October 30, 2014TEAS EXTENSION RECEIVED
Wednesday, May 28, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 27, 2014SOU EXTENSION 2 GRANTED
Friday, May 2, 2014SOU EXTENSION 2 FILED
Tuesday, May 27, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 2, 2014TEAS EXTENSION RECEIVED
Tuesday, November 12, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 8, 2013SOU EXTENSION 1 GRANTED
Friday, November 8, 2013SOU EXTENSION 1 FILED
Friday, November 8, 2013TEAS EXTENSION RECEIVED
Tuesday, May 28, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 2, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 2, 2013PUBLISHED FOR OPPOSITION
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 13, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 25, 2013ELECTRONIC RECORD REVIEW COMPLETE
Friday, February 22, 2013ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, February 14, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 13, 2013ASSIGNED TO EXAMINER
Wednesday, November 7, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 5, 2012NEW APPLICATION ENTERED

Related Keywords

lyrdroi pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological